OPTIMIZATION OF PARENTAL ATTENTION ON SOCIAL SCIENCES MAJOR LEARNING OUTCOMES DURING PANDEMIC IN MTs NEGERI GOWA
International Journal of Multidisciplinary Research and Literature · 2022
DOI: 10.53067/ijomral.v1i2.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Multidisciplinary Research and Literature, 2022. Verfasst von Sitti Marlina. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
The purpose of this study was to determine optimizing parental attention on social sciences primary learning outcomes during the pandemic at MTs Negeri Gowa. I conducted the Odd Semester of 2020/2021 Academic Year research. This research took place in MTs Negeri Gowa. The population of this research is 100 students of class VIII MTs Negeri Gowa, and the sample is as many as 80 students. The research method used is a quantitative approach. The independent variable is parental attention (X), and the dependent variable (Y) is student learning outcomes in social sciences subjects. Data collection techniques include questionnaires, documentation, and interviews. Based on the results of research hypothesis testing, the results of a regression coefficient of 0.081 with a significance value of 0.045
Zitieren
APA
Marlina, S. (2022). OPTIMIZATION OF PARENTAL ATTENTION ON SOCIAL SCIENCES MAJOR LEARNING OUTCOMES DURING PANDEMIC IN MTs NEGERI GOWA. International Journal of Multidisciplinary Research and Literature. https://doi.org/10.53067/ijomral.v1i2.13
Vancouver
Marlina S. OPTIMIZATION OF PARENTAL ATTENTION ON SOCIAL SCIENCES MAJOR LEARNING OUTCOMES DURING PANDEMIC IN MTs NEGERI GOWA. International Journal of Multidisciplinary Research and Literature. 2022. doi:10.53067/ijomral.v1i2.13
BibTeX
@article{Marlina2022,
author = {Marlina, Sitti},
title = {OPTIMIZATION OF PARENTAL ATTENTION ON SOCIAL SCIENCES MAJOR LEARNING OUTCOMES DURING PANDEMIC IN MTs NEGERI GOWA},
journal = {International Journal of Multidisciplinary Research and Literature},
year = {2022},
doi = {10.53067/ijomral.v1i2.13}
}
EUVIMED